Literature DB >> 18293203

A comparison of circulating TNF-alpha in obese and lean women with and without preeclampsia.

Sandra A Founds1, Robert W Powers, Thelma E Patrick, Dianxu Ren, Gail F Harger, Nina Markovic, James M Roberts.   

Abstract

OBJECTIVES: We hypothesized that TNF-alpha would be higher in obese versus lean women with preeclampsia.
METHODS: Total plasma TNF-alpha was measured in a nested case-control study of 123 nulliparous lean and obese control women and women with preeclampsia.
RESULTS: Adjusted mean TNF-alpha concentrations were 0.97 +/- 0.11 (pg/mL +/- SEM) in lean controls, 1.01 +/- 0.10 in obese controls, 1.43 +/- 0.11 in lean women with preeclampsia and 1.16 +/- 0.11 in obese women with preeclampsia. Pregnancy outcome was the single predictor of TNF-alpha concentration in the general linear regression model (p = 0.04).
CONCLUSION: TNF-alpha concentration was higher in preeclampsia compared with control subjects. Obesity was not associated with higher TNF-alpha concentrations in either preeclampsia or control subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18293203      PMCID: PMC2675917          DOI: 10.1080/10641950701825838

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  28 in total

1.  An innate view of human pregnancy.

Authors:  G Sacks; I Sargent; C Redman
Journal:  Immunol Today       Date:  1999-03

2.  Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia.

Authors:  Y Hamai; T Fujii; T Yamashita; H Nishina; S Kozuma; Y Mikami; Y Taketani
Journal:  Am J Reprod Immunol       Date:  1997-08       Impact factor: 3.886

Review 3.  The new concept of adipose tissue function.

Authors:  Hans Hauner
Journal:  Physiol Behav       Date:  2004-12-30

4.  Circulating levels of immunoreactive cytokines in women with preeclampsia.

Authors:  K P Conrad; T M Miles; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1998-08       Impact factor: 3.886

Review 5.  Etiology and pathogenesis of preeclampsia: current concepts.

Authors:  G A Dekker; B M Sibai
Journal:  Am J Obstet Gynecol       Date:  1998-11       Impact factor: 8.661

6.  Tumor necrosis factor-alpha in the placenta is not elevated in pre-eclamptic patients despite its elevation in peripheral blood.

Authors:  Masatoshi Hayashi; Yoshihiko Ueda; Takehiko Yamaguchi; Ryoichi Sohma; Mitsuei Shibazaki; Takeyoshi Ohkura; Noriyuki Inaba
Journal:  Am J Reprod Immunol       Date:  2005-03       Impact factor: 3.886

Review 7.  Placental cytokines and the pathogenesis of preeclampsia.

Authors:  K P Conrad; D F Benyo
Journal:  Am J Reprod Immunol       Date:  1997-03       Impact factor: 3.886

8.  Short- and long-term changes in plasma inflammatory markers associated with preeclampsia.

Authors:  Dilys J Freeman; Frances McManus; Elizabeth Ann Brown; Lynne Cherry; John Norrie; Jane E Ramsay; Peter Clark; Isobel D Walker; Naveed Sattar; Ian A Greer
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

Review 9.  Tumor necrosis factors: pivotal components of pregnancy?

Authors:  J S Hunt; H L Chen; L Miller
Journal:  Biol Reprod       Date:  1996-03       Impact factor: 4.285

Review 10.  Endothelial dysfunction in preeclampsia.

Authors:  J M Roberts
Journal:  Semin Reprod Endocrinol       Date:  1998
View more
  11 in total

Review 1.  Epidemiology of preeclampsia: impact of obesity.

Authors:  Arun Jeyabalan
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

2.  Intraabdominal fat, insulin sensitivity, and cardiovascular risk factors in postpartum women with a history of preeclampsia.

Authors:  Darcy R Barry; Kristina M Utzschneider; Jenny Tong; Kersten Gaba; Daniel F Leotta; John D Brunzell; Thomas R Easterling
Journal:  Am J Obstet Gynecol       Date:  2015-05-21       Impact factor: 8.661

3.  Association of inflammatory cytokines, lipid peroxidation end products and nitric oxide with the clinical severity and fetal outcome in preeclampsia in Indian women.

Authors:  Devika Tayal; Binita Goswami; S K Patra; Reva Tripathi; Alka Khaneja
Journal:  Indian J Clin Biochem       Date:  2013-04-13

Review 4.  Impact of pregravid obesity on maternal and fetal immunity: Fertile grounds for reprogramming.

Authors:  Suhas Sureshchandra; Nicole E Marshall; Ilhem Messaoudi
Journal:  J Leukoc Biol       Date:  2019-09-04       Impact factor: 4.962

5.  The Role of Obesity in Preeclampsia.

Authors:  James M Roberts; Lisa M Bodnar; Thelma E Patrick; Robert W Powers
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

6.  Is there evidence of separate inflammatory or metabolic forms of preeclampsia?

Authors:  Sandra A Founds; Janet M Catov; Marcia J Gallaher; Gail F Harger; Nina Markovic; James M Roberts
Journal:  Hypertens Pregnancy       Date:  2010-05-12       Impact factor: 2.108

7.  Mechanisms and Treatment of Halogen Inhalation-Induced Pulmonary and Systemic Injuries in Pregnant Mice.

Authors:  James A Lambert; Matthew A Carlisle; Adam Lam; Saurabh Aggarwal; Stephen Doran; Changchun Ren; Wayne E Bradley; Louis Dell'Italia; Namasivayam Ambalavanan; David A Ford; Rakesh P Patel; Tamas Jilling; Sadis Matalon
Journal:  Hypertension       Date:  2017-06-12       Impact factor: 10.190

8.  Psychological distress and SSRI use predict variation in inflammatory cytokines during pregnancy.

Authors:  Gwen Latendresse; R Jeanne Ruiz; Bob Wong
Journal:  Open J Obstet Gynecol       Date:  2013-02

Review 9.  Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms.

Authors:  Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-07       Impact factor: 3.619

10.  Follistatin-like 3 across gestation in preeclampsia and uncomplicated pregnancies among lean and obese women.

Authors:  Sandra A Founds; Dianxu Ren; James M Roberts; Arun Jeyabalan; Robert W Powers
Journal:  Reprod Sci       Date:  2014-04-03       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.